These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 30685251

  • 1. Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel® in mice.
    Coelho CH, Gazzinelli-Guimaraes PH, Howard J, Barnafo E, Alani NAH, Muratova O, McCormack A, Kelnhofer E, Urban JF, Narum DL, Anderson C, Langhorne J, Nutman TB, Duffy PE.
    Vaccine; 2019 Feb 14; 37(8):1038-1045. PubMed ID: 30685251
    [Abstract] [Full Text] [Related]

  • 2. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
    Healy SA, Anderson C, Swihart BJ, Mwakingwe A, Gabriel EE, Decederfelt H, Hobbs CV, Rausch KM, Zhu D, Muratova O, Herrera R, Scaria PV, MacDonald NJ, Lambert LE, Zaidi I, Coelho CH, Renn JP, Wu Y, Narum DL, Duffy PE.
    J Clin Invest; 2021 Apr 01; 131(7):. PubMed ID: 33561016
    [Abstract] [Full Text] [Related]

  • 3. Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial.
    Sagara I, Healy SA, Assadou MH, Kone M, Swihart BJ, Kwan JL, Fintzi J, Sissoko K, Kamate B, Samake Y, Guindo MA, Doucoure M, Niaré K, Dolo A, Diarra B, Rausch KM, Narum DL, Jones DS, MacDonald NJ, Zhu D, Gorres JP, Imeru A, Mohan R, Thera I, Zaidi I, Salazar-Miralles F, Duan J, Neal J, Morrison RD, Muratova O, Sylla D, O'Connell EM, Wu Y, Hume JCC, Coulibaly MB, Anderson CF, Traore SF, Doumbo OK, Duffy PE.
    Lancet Infect Dis; 2023 Nov 01; 23(11):1266-1279. PubMed ID: 37499679
    [Abstract] [Full Text] [Related]

  • 4. The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate.
    Lee SM, Wu Y, Hickey JM, Miura K, Whitaker N, Joshi SB, Volkin DB, Richter King C, Plieskatt J.
    Malar J; 2019 Nov 08; 18(1):356. PubMed ID: 31703583
    [Abstract] [Full Text] [Related]

  • 5. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
    Infect Immun; 2005 Nov 08; 73(11):7375-80. PubMed ID: 16239536
    [Abstract] [Full Text] [Related]

  • 6. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.
    MacDonald NJ, Nguyen V, Shimp R, Reiter K, Herrera R, Burkhardt M, Muratova O, Kumar K, Aebig J, Rausch K, Lambert L, Dawson N, Sattabongkot J, Ambroggio X, Duffy PE, Wu Y, Narum DL.
    J Biol Chem; 2016 Sep 16; 291(38):19913-22. PubMed ID: 27432885
    [Abstract] [Full Text] [Related]

  • 7. B cell clonal expansion and mutation in the immunoglobulin heavy chain variable domain in response to Pfs230 and Pfs25 malaria vaccines.
    Coelho CH, Galson JD, Trück J, Duffy PE.
    Int J Parasitol; 2022 Oct 16; 52(11):707-710. PubMed ID: 34896314
    [Abstract] [Full Text] [Related]

  • 8. Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle.
    Shimp RL, Rowe C, Reiter K, Chen B, Nguyen V, Aebig J, Rausch KM, Kumar K, Wu Y, Jin AJ, Jones DS, Narum DL.
    Vaccine; 2013 Jun 19; 31(28):2954-62. PubMed ID: 23623858
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.
    Radtke AJ, Anderson CF, Riteau N, Rausch K, Scaria P, Kelnhofer ER, Howard RF, Sher A, Germain RN, Duffy P.
    Sci Rep; 2017 Jan 16; 7():40312. PubMed ID: 28091576
    [Abstract] [Full Text] [Related]

  • 10. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
    Singh K, Burkhardt M, Nakuchima S, Herrera R, Muratova O, Gittis AG, Kelnhofer E, Reiter K, Smelkinson M, Veltri D, Swihart BJ, Shimp R, Nguyen V, Zhang B, MacDonald NJ, Duffy PE, Garboczi DN, Narum DL.
    Commun Biol; 2020 Jul 24; 3(1):395. PubMed ID: 32709983
    [Abstract] [Full Text] [Related]

  • 11. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell Responses.
    Bjerkan L, Visweswaran GRR, Gudjonsson A, Labbé GM, Quinkert D, Pattinson DJ, Spång HCL, Draper SJ, Bogen B, Braathen R.
    Front Immunol; 2021 Jul 24; 12():720550. PubMed ID: 34733274
    [Abstract] [Full Text] [Related]

  • 12. Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.
    Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE.
    PLoS One; 2016 Jul 24; 11(10):e0163144. PubMed ID: 27749907
    [Abstract] [Full Text] [Related]

  • 13. ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.
    Miura K, Deng B, Wu Y, Zhou L, Pham TP, Diouf A, Wu CK, Lee SM, Plieskatt JL, Morin MJ, Long CA.
    Vaccine; 2019 Apr 03; 37(15):2073-2078. PubMed ID: 30850239
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
    Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, Tembine I, Guindo MA, Doucoure M, Niaré K, Dolo A, Rausch KM, Narum DL, Jones DL, MacDonald NJ, Zhu D, Mohan R, Muratova O, Baber I, Coulibaly MB, Fay MP, Anderson C, Wu Y, Traore SF, Doumbo OK, Duffy PE.
    Lancet Infect Dis; 2018 Sep 03; 18(9):969-982. PubMed ID: 30061051
    [Abstract] [Full Text] [Related]

  • 15. Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230.
    Scaria PV, Chen BB, Rowe CG, Alani N, Muratova OV, Barnafo EK, Lambert LE, Zaidi IU, Lees A, Rausch KM, Narum DL, Duffy PE.
    Vaccine; 2020 Jul 22; 38(34):5480-5489. PubMed ID: 32600913
    [Abstract] [Full Text] [Related]

  • 16. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
    Coban C, Philipp MT, Purcell JE, Keister DB, Okulate M, Martin DS, Kumar N.
    Infect Immun; 2004 Jan 22; 72(1):253-9. PubMed ID: 14688103
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
    Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebié I, Faber B, Remarque E, Launay O, AMA1-DiCo Study Group.
    Vaccine; 2017 Oct 27; 35(45):6218-6227. PubMed ID: 28947345
    [Abstract] [Full Text] [Related]

  • 18. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T.
    Infect Immun; 2013 Dec 27; 81(12):4377-82. PubMed ID: 24042109
    [Abstract] [Full Text] [Related]

  • 19. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA, Vega-Rodriguez J, Flores-Garcia Y, Noe AR, Muñoz C, Coleman R, Bruck T, Haney K, Stevens A, Retallack D, Allen J, Vedvick TS, Fox CB, Reed SG, Howard RF, Salman AM, Janse CJ, Khan SM, Zavala F, Gutierrez GM.
    Infect Immun; 2017 Feb 27; 85(2):. PubMed ID: 27895131
    [Abstract] [Full Text] [Related]

  • 20. Plasmodium falciparum and Helminth Coinfections Increase IgE and Parasite-Specific IgG Responses.
    Santano R, Rubio R, Grau-Pujol B, Escola V, Muchisse O, Cuamba I, Vidal M, Cisteró P, Ruiz-Olalla G, Aguilar R, Demontis M, Jamine JC, Cossa A, Sacoor C, Cano J, Izquierdo L, Chitnis CE, Coppel RL, Chauhan V, Cavanagh D, Dutta S, Angov E, Gaur D, van Lieshout L, Zhan B, Muñoz J, Moncunill G, Dobaño C.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0110921. PubMed ID: 34878303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.